Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States-Reference-Cited by-同舟云学术

Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States

Published:2022-04-14 Issue:1 Volume:43 Page:943-948
ISSN:0889-7077
Container-title:Substance Abuse
language:en
Short-container-title:Substance Abuse

Author:

Wadsworth Elle¹^ORCID,Hines Lindsey A.²³^ORCID,Hammond David¹^ORCID

Affiliation:

1. School of Public Health Sciences, University of Waterloo, Waterloo, Canada

2. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK

3. Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK

Funder

Canadian Institutes of Health Research Project Bridge

Canadian Institutes of Health Research

Public Health Agency of Canada-Canadian Institutes of Health Research Chair in Applied Public Health

Vanier Canada Graduate Scholarship

Wellcome Trust

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/08897077.2022.2060431

Reference32 articles.

1. Legalization of Medical Marijuana and Incidence of Opioid Mortality

2. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations

3. Perspectives on cannabis as a substitute for opioid analgesics

4. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014

5. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association of Medical Cannabis Use with Pain Levels and Opioid Use in Illinois’ Opioid Alternative Pilot Program;Substance Use & Misuse;2024-07-28

2. ACOG Clinical Consensus No. 7: The Use of Cannabis Products for the Management of Pain Associated With Gynecologic Conditions;Obstetrics & Gynecology;2024-07

3. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic;Journal of Opioid Management;2024-04-01

4. Characteristics of patients with non-cancer pain and long-term prescription opioid use who have used medical versus recreational marijuana;Journal of Cannabis Research;2024-02-22

5. Association of cannabis use with patient-reported pain measures among adults with chronic pain in US states with medical cannabis programs;Regional Anesthesia & Pain Medicine;2023-11-03